Emilie Mirey
  • Institut de Pharmacologie et de Biologie Structurale (IPBS) CNRS, Université de Toulouse UPS, France, France,
Research fields
  • Immunology
Personal information


PhD in oncology, University of Toulouse, FRANCE, 2014

Current position

Research Associate in in vivo pharmacology group, Translational biology departement, EVOTEC, FRANCE


  1. Lefrancais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C. and Girard, J. P. (2014). Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A 111(43): 15502-15507. 

  2. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N. and Girard, J. P. (2012). Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188(7): 3488-3495.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.